UnitedHealth GroupĀ (NYSE:UNH) reported earnings today, beating on the top and bottom lines. Excellent.

But let's dig a little deeper, to the business behind the numbers. The key question for investors to ask is whether UnitedHealth Group is fundamentally healthy under the positive top-and-bottom line news.

In the video below, Motley Fool health care analysts Michael Douglass and David Williamson lay out three key takeaways from UNH's second quarter earnings.

An even bigger story than UnitedHealth Group?
Let's face it -- the best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

David Williamson owns shares of UnitedHealth Group. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group and owns and recommends shares of Gilead Sciences. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.